Literature DB >> 10147479

Ultrapulse carbon dioxide laser removal of periocular wrinkles in association with laser blepharoplasty.

C Weinstein1.   

Abstract

Removal of periocular wrinkles is a common yet difficult problem. There are many techniques currently available, all of which have some drawbacks. With the advent of new generation ultrapulse carbon dioxide lasers, skin can now be resurfaced successfully with minimal risk and side effects. In our study of 36 patients we assessed the benefit of using ultrapulse carbon dioxide (CO 2) laser to resurface the periorbital skin in association with transconjunctival lower lid CO 2 laser blepharoplasty. We found that 36/36 (100%) patients had good to excellent results. The incidence of side effects was very low. We also found that 2/36 (5.6%) of patients developed mild clinically insignificant hypopigmentation and 1/36 (2.8%) developed mild scarring, which resolved with one injection of triamanalone 10 mg/ml. No patients had hyperpigmentation. In addition, 1/36 (2.8%) patients developed transient ectropion, which resolved spontaneously in 6 weeks. We conclude that ultrapulse CO 2 laser is an excellent method for treating periocular wrinkle lines and can be readily performed in conjunction with a transconjunctival lower lid blepharoplasty.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10147479     DOI: 10.1089/clm.1994.12.205

Source DB:  PubMed          Journal:  J Clin Laser Med Surg        ISSN: 1044-5471


  3 in total

1.  Periocular skin reshaping by CO2 laser coagulation.

Authors:  M A Trelles; I Kaplan; J Rigau; O Buezo
Journal:  Aesthetic Plast Surg       Date:  1996 Jul-Aug       Impact factor: 2.326

Review 2.  Facial rejuvenation techniques.

Authors:  F E Barton
Journal:  Mund Kiefer Gesichtschir       Date:  1997-11

3.  Safety and efficacy of fractional radiofrequency for the treatment and reduction of acne scarring: A prospective study.

Authors:  Stephen W Eubanks; James A Solomon
Journal:  Lasers Surg Med       Date:  2021-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.